Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy

This study has been terminated.
(Changes to surgical practices led to the loss of eligible patients for this study.)
Information provided by (Responsible Party):
University of Oklahoma Identifier:
First received: August 13, 2008
Last updated: March 17, 2017
Last verified: March 2017

August 13, 2008
March 17, 2017
November 6, 2008
September 2009   (Final data collection date for primary outcome measure)
Post operative pain is reduced when single pre-operative oral dose of Gabapentine is given to the patient before the Inguinal Herniorrhaphy [ Time Frame: 1yrs ]
Same as current
Complete list of historical versions of study NCT00735124 on Archive Site
The post operative analgesia requirement is also reduced [ Time Frame: 1yrs ]
Same as current
Not Provided
Not Provided
Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy
An Investigation of Post-Operative Pain Scores and Analgesic Requirements After Ambulatory Inguinal Herniorrhaphy With Pre-Operative Gabapentin Therapy
The study will investigate the effects of single dose pre-operative oral dose of gabapentin (1200) on post -operative pain scores and oral analgesic requirements.
The study will benefit patients in reducing post-operative pain scores as well as reduction in oral analgesic consumption. Gabapentin has been shown to reduce post operative pain pain scores in breast surgery, hysterectomy , spinal surgery, orthopedic and thyroid surgery
Phase 2
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Participant, Care Provider, Investigator, Outcomes Assessor
Primary Purpose: Treatment
  • Pain
  • Analgesia
  • Hernia, Inguinal
  • Drug: Gabapentin
    1200 mg single dose gabapentin
    Other Name: Neurtonin
  • Other: Sham or placebo
    Injection of placebo/sham
    Other Name: placebo
  • Active Comparator: Single pre-op dose of Gabapentine
    Active treatment with the study drug
    Intervention: Drug: Gabapentin
  • Placebo Comparator: Placebo
    Placebo arm for blinding the medication
    Intervention: Other: Sham or placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
September 2009
September 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects having elective surgery with open unilateral Inguinal herniorraphy

Exclusion Criteria:

  • Non elective surgery
  • Patients currently on gabapentin therapy
  • Patient hypersensitive to gabapentin surgery
  • History of alcohol or drug abuse
  • Patients who are pregnant or who are nursing
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Not Provided
University of Oklahoma
University of Oklahoma
Not Provided
Principal Investigator: Badie Mansour, MD OUHSC
University of Oklahoma
March 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP